Tom Kmiec

Canada's Drug Agency policies as it relates to reimbursement recommendation decision-making process and framework Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry. Federal policies that relate to possible models of pharmacare Federal Buy Canadian Procurement Policy as it relates to government drug procurement practices and the implications for the biopharmaceutical industry Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations National Strategy for Drugs for Rare Diseases World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the biopharmaceutical industry World Health Organization (WHO) issues concerning the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Income Tax Act as it relates to biopharmaceutical products Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade agreements as they relate to the biopharmaceutical industry Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry

National Strategy for Drugs for Rare Diseases Income Tax Act as it relates to biopharmaceutical products Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry Activities related to the Convention on Biological Diversity (CBD) including Digital Sequence Information (DSI) and an Access and Benefit Sharing (ABS) framework. Canada-United States Regulatory Cooperation Council (RCC) initiatives related to the regulation of biopharmaceutical products Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Free trade treaty agreement as they relate to The Canada-United States-Mexico Agreement (CUSMA) and free trade negotiations as it relates to India, the European Union, Japan, MERCOSUR and the Trans-Pacific Partnership Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Subsequent Entry Biologics (SEBs) as it relates to Regulations, Policies, or Guidelines being developed by Health Canada, specifically the Draft Guidance Document on SEBs, the Notices of Changes to Health Canada's Guidance Documents on Data Protection and Patented Medicines Regulations (Notice of Compliance) Regulations World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" Scientific Research and Experimental Development (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products World Health Organization (WHO) issues concerning pharmaceuticals as it relates to Counterfeits, Access to Medicines, and the Intergovernmental Working Group (IGWG) World Intellectual Property Organization (WIPO) issues concerning the protection of and access to intellectual property Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework Establish accountability with the federally financed Canadian Agency for Drugs and Technologies in Health (CADTH) Proposed pharmacare legislation related to any future national pharmacare program Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease

Communicating with government officials about improved health outcomes, including, but not limited to (i) expanding equitable access to innovative therapies, diagnostics and vaccines, (ii) promoting pricing reform, (iii) enhancing health security, including via the Health Emergency Readiness Canada ("HERC") Agency and (iv) promoting regulatory efficiency and modernization, including through the Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs. Communicating with government officials about the implementation and expansion of the national pharmacare program, including as it relates to the Pharmacare Act, S.C. 2024, c. 24. Communicating with government officials about the implementation, renewal and expansion of the "National Strategy for Drugs for Rare Diseases" (2023). Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy. Communicating with government officials about international trade agreements, including the Canada-United States-Mexico Agreement (CUSMA), formerly known as the North American Free Trade Agreement (NAFTA), more specifically as it relates to trade in the life sciences and biopharmaceutical sectors. Communicating with government officials about international trade, more specifically tariffs and non-tariff trade barriers affecting the life sciences and biopharmaceutical sectors. Communicating with government officials about regulations, guidelines, reviews, references and reporting requirements issued by and/or related to the Patented Medicine Prices Review Board ("PMPRB"). Communicating with government officials about regulations related to patented medicines, including the "Patented Medicines (Notice of Compliance) Regulations" (SOR/93-133) under the Patent Act. Communicating with government officials about a national pharmaceutical strategy, more specifically as it relates to (i) enhanced access to orphan drugs and (i) incentives for the development of rare disorder treatments. Communicating with government officials about the Food and Drugs Act, including about (i) the approval framework for drug products, such as subsequent entry biologics (also known as biosimilars), (ii) export and cross-border trade restrictions for drug products, (iii) data exclusivity for drug products, (iv) approvals (and subsequent reviews) for new drug submissions, and (v) post-market surveillance of drug products. Communicating with government officials about federal healthcare plans and benefits. Communicating with government officials about the Government of Canada's "Biomanufacturing and Life Sciences Strategy" (2021). Communicating with government officials about programs, reports, reviews and policies issued by or related to Canada's Drug Agency (formerly known as the Canadian Agency for Drugs and Technologies in Health). Communicating with government officials about the pan-Canadian Health Data Strategy, more specifically about health data foundations.

The CUSMA renegotiation and issues related to the pharmaceutical industry in Canada. Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to provide industry recommendations on Canada's Biomanufacturing and Life Sciences Strategy, as well as the Intellectual Property performance review, as noted in budget 2026. Free trade agreements as they relate to biomanufacturing industry in Canada. Engage, as a stakeholder, to provide input into the re-negotiation of the Canada USA Mexico trade agreement "CUSMA" Patented Medicines Regulations modernization as outlined in Budget 2026, that will leverage existing technology, enabling faster and more cost effective procedural processes. Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada. R&D requirements set forth through the Patent Medicines Pricing Review Board (PMPRB) Patented Medicine Prices Review Board (PMPRB) Regulations as related to reporting requirements and pricing guidelines. Federal Public Drug Plans, with respect to the reimbursement of drug products for the Federal plan beneficiaries Canadian Agency for Drugs and Technologies in Health (CADTH), including Therapeutic Reviews and the Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.

Free trade agreements as they relate to biomanufacturing industry in Canada Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to provide industry recommendations on Canada's Biomanufacturing and Life Sciences Strategy, National Pharmacare, Intellectual property as well as pricing reforms (PMPRB) Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada. R&D requirements set forth through the Patent Medicines Pricing Review Board (PMPRB) Patent Medicines Pricing Review Board reforms, regarding both the revised regulations and draft guidelines Patented Medicines (Notice of Compliance) Regulations as it relates to regulation of intellectual property for therapeutic products. Novartis is working with our industry associations (Innovative Medicines Canada and BIOTECanada) to provide a written response to Guideline consultation process and will provide our own corporate submission. Patented Medicine Prices Review Board (PMPRB) Regulations as related to reporting requirements and pricing guidelines. Federal Public Drug Plans, with respect to the reimbursement of drug products for the Federal plan beneficiaries Federal Innovation agenda. Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to ensure that innovative medicines, and our contribution to Research and Development in Canada are part of the consultation process in the development of this new innovation agenda. Canadian Agency for Drugs and Technologies in Health (CADTH), including Therapeutic Reviews and the Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.

Advocacy regarding pending CRTC review of Wireless Code Replacement Worker Legislation - TELUS is interested in legislation that bans replacement workers during a labour dispute as it would hinder our ability to operate and provide ongoing service to customers. Providing input to the government for development of an anti-fraud strategy to create an integrated fraud takedown framework. Discussions regarding federal support for science and research talent development, with a focus on creating public-private partnerships that enhance education and training opportunities. These efforts aim to advance social good by increasing the participation of women and marginalized groups in the digital economy and STEM sectors. Developing protocols for Canada’s Greenhouse Gas Offset Credit System Advocacy for potential amendments to the Copyright Act, with respect to updating unclear regulation of Internet Service Providers. Advocacy regarding fibre-to-the-premises wholesale access; including discussions about TELUS' expansion and extended offerings. Advocacy regarding improving resilience and redundancy in TELUS’ network, including the potential to expand remote network connectivity and build out critical infrastructure in the North. Communicating with the government about how to support adopting digital tools in the agriculture sector. Advocacy concerning the development and implementation of national artificial intelligence policies, including but not limited to the Sovereign AI Compute Strategy and the AI Compute Access Fund. Informing officials about TELUS' plans to monetize passive infrastructure. Informing Federal officials about the risks posed by copper theft to public safety and telecommunications infrastructure, and advocating for enhanced collaboration between governments (provincial and federal) and industry to address this growing issue effectively. Advocating for stricter regulations around theft and damage of telecommunications infrastructure through Bill C-26: An Act respecting cyber security, amending the Telecommunications Act and making consequential amendments to other Acts. Review of the Personal Information Protection and Electronic Documents Act (PIPEDA) as relates to communications and data service providers’ obligations Regulatory environment affecting the Canadian wireless market, including regulatory framework with regard to the requirements around rural network infrastructure builds, the policy framework around spectrum auction rules and regulations on the purchase of existing Canadian wireless companies. Potential Amendments to the Broadcasting and Telecommunication Acts, with respect to streamlining regulation of the broadcasting and telecommunication industry. Policy framework with respect to the relationship between digital/wireless connectivity and climate policy. Policy Framework with regard to the terms and conditions of auction for Spectrum Licences Informing Federal officials around TELUS initiatives in the Health Care field and communicating the need for increased cooperation in developing next generation health care services between all levels of Government. Critical infrastructure and cyber security - protection of facilities, networks, technology, assets and systems. Canadian Radio-television and Telecommunications Commission review of Basic Telecommunications Services Broadcasting Policies Relating to Specialty Television Broadcasting Policies Relating to Conventional Television Broadband Canada – Connect to Innovate program which is of interest to TELUS, with respect to advancing rural and remote network connectivity in Canada. Bills related to lawful access obligations that will have a direct impact on the Company from a financial and operational perspective, as well as impact on TELUS customers from a privacy perspective, and with respect to obligations imposed on carriers with respect to intercept and subscriber information. As a supplier to the Government of Canada, TELUS regularly engages in di

Engage with government on on building multi residential housing units with the fibre and home security systems of TELUS. Broadband Canada – Connect to Innovate program which is of interest to TELUS, with respect to advancing rural and remote network connectivity in Canada. Engage with government to raise awareness on copper theft and advance policy solutions. Spectrum policy framework as related to incumbent wireless carriers with respect to all technological and financial implications of proposed government policies. Review of the Personal Information Protection and Electronic Documents Act (PIPEDA) as relates to communications service providers’ obligations Replacement Worker Legislation - TELUS is interested in legislation that bans replacement workers during a labour dispute as it would hinder our ability to operate our organization and serve our customers. Regulatory environment affecting the Canadian wireless market, including regulatory framework with regard to the requirements around rural network infrastructure builds, the policy framework around spectrum auction rules and regulations on the purchase of existing Canadian wireless companies. Proposed Digital Economy Strategies with respect to spectrum and environmental policy. Potential Amendments to the Broadcasting and Telecommunication Acts, with respect to streamlining regulation of the broadcasting and telecommunication industry. Policy framework with respect to the relationship between digital/wireless connectivity and climate policy. Policy Framework with regard to the terms and conditions of auction for Spectrum Licenses. Informing Federal officials around TELUS initiatives in the Health Care field and communicating the need for increased cooperation in developing next generation health care services between all levels of Government. Critical infrastructure and cybersecurity - protection of facilities, networks, technology, assets and systems. Copyright regulations and the Copyright Modernization Act with respect to the scheduled five year review. Communicating with the government about adopting digital tools in the agriculture sector. Canadian Radio-television and Telecommunications Commission review of Basic Telecommunications Services Broadcasting Policies Relating to Specialty Television Broadcasting Policies Relating to Conventional Television Bills related to lawful access obligations that will have a direct impact on the Company from a financial and operational perspective, as well as impact on TELUS customers from a privacy perspective, and with respect to obligations imposed on carriers with respect to intercept and subscriber information. As a supplier to the Government of Canada, TELUS regularly engages in discussions related approaches to reduce costs in the procurement of end-user devices, networks and associated support services and solutions.

Support for new research and campus infrastructure. Increased funding and program design for various programs administered by Social Sciences and Humanities Research Council (SSHRC), Natural Sciences and Engineering Research Council (NSERC), and Canadian Institutes of Health Research (CIHR). Funding or support with respect to international development cooperation (student and academic mobility, internships, research collaboration, exchanges, technical assistance). Discussions regarding possible research and development initiatives for, and investments in, partnerships with the University of Calgary. Discussions concerning potential research and development initiatives and investments related to clean energy, environmental research and climate change policy. Discussions about policy implementation regarding the academic visa process in support of international faculty recruitment with respect to changes to the Immigration and Refugee Protection Regulations. Budget bills in support of federal funding for post-secondary education, research, innovation, science and technology.

Agricultural trade: multi and bi-lateral trade negotiations to maintain and expand opportunities for canola farmers through reduction in tariffs and non-tariff trade barriers. Provide farmers necessary support through trade disruptions. Support the modernization of the World Trade Organization (WTO) as a mechanism to promote rules-based trade. Support additional government resources to help solve technical trade barriers. Inter-provincial regulations support canola production, market access, and growth. Agriculture Policy Framework: ensure that business risk management programs and strategic initiatives are suitable for canola farmers. Federal research programming and initiatives support production needs on farm. Support right to repair and interoperability programs, policies, laws, and regulations that support farmer's choice and right to repair. Canada Transportation Act and regulations as it relates to the transportation of grain. Support development of transportation and trade infrastructure that facilities market demand and growth for canola. Ensure governments recognize the benefits that farmers provide to the environment, including in relation to offset protocols, ecological goods and services, and rebates. Support on-farm exemptions for carbon pricing. Climate change laws, policies, programs, research, and regulations related to agriculture promote competitiveness and production on farms. Environment and international trade: to advance the good management practices that are implemented on canola farms that contribute to environmental stewardship and competitive markets for farmers and to advance the canola biodiesel market domestically and abroad. Canada's Clean Fuel Regulations incentivizes the use of canola-based biofuels. Transportation: to advocate for a fair and efficient railway transportation system that serves the needs of grain producers. The creation and implementation of the Canada Water Agency and adoption of a pan-Canadian water monitoring framework have positive impacts for canola farmers. Support enhanced resources for federal regulatory bodies to make science-based decisions on crop protection products and seed varieties. Seeds Act and regulations as it pertains to seed variety registrations. Plant Breeders Rights Act and regulations as it relates to intellectual property rights. Patent Act and regulations as it pertains to intellectual property rights specific to seed technologies. Income Tax Act and other financial regulations, policies or programs: To promote the fair treatment of farmers in any proposed changes to the Income Tax Act or other financial mechanism that may impact farmers financially. Fisheries Act regulations and polices as it relates to fish habitats on farmland. Ensure Government recognizes and works with the agriculture sector to ensure farmers have access to skilled, competitive on-farm labour. Discussions concerning railway and port strikes as it relates to economic development and trade labour disruptions. Canadian Food Inspection Act and regulations as it relates to canola production and trade. Canadian Environmental Protection Act and Pest Control Products Act and regulations as it relates to agricultural pest control products. Canada Grain Act and Canada Grain Act Regulations as it relates to grain handling and transportation. Broadband: Expedite and support efforts to bring affordable, reliable high-speed internet and mobile coverage to rural and remote communities. Agricultural Marketing Programs Act and regulations as it pertains to the Advance Payments Program.

The creation and implementation of the Canada Water Agency and adoption of a pan-Canadian water monitoring framework have positive impacts for canola farmers. Support passage of C-294, An Act to amend the Copyright Act (interoperability), to support production, competitiveness, and working capital on farm. Support passage of C-244, An Act to amend the Copyright Act (diagnosis, maintenance and repair), to support production, competitiveness, and working capital on farm. Support passage of Bill C-234, An Act to Amend the Greenhouse Gas Pollution Pricing Act, to further enable farmers' role as climate solutions providers and support competitiveness. Support Bill C-359, An Act to amend the Feeds Act, the Seeds Act and the Pest Control Products Act (provisional registration and approval), to promote production, innovation, and competitiveness on farm. Support a review of the Canada Grains Act to modernize role of Canadian Grain Commission to align with needs of the grain sector. Income Tax Act and other financial regulations, policies or programs: To promote the fair treatment of farmers in any proposed changes to the Income Tax Act or other financial mechanism that may impact farmers financially. Ensure governments recognize the benefits that farmers provide to the environment. Including in relation to polices and regulations concerning carbon pricing, as it pertains to on-farm exemptions, offset protocols, rebates, and research. Climate change laws, policies, programs and regulations related to agriculture promote competitiveness and production on farms. Concern Bill C-282, An Act to amend the Department of Foreign Affairs, Trade and Development Act (supply management) will cause negative impacts to Canada’s trade agenda. Climate/Environment- Advance canola- based biofuel as part of the solution for climate change. Canada's Clean Fuel Standard (CFS) incentivizes the use of canola-based biofuels. Canadian Environmental Protection Act and Pest Control Products Act and regulations as it relates to agricultural pest control products. Support enhanced resources for federal regulatory bodies to make science-based decisions on crop protection products and seed varieties. Advocate for clear, science and risk-based approach to regulation of pesticides and new plant breeding innovation and that it is facilitative for trade. Canada Transportation Act and regulations as it relates to the transportation of grain. Advocate for a fair and efficient railway transportation system that serves the needs of grain producers. Agriculture - Work to ensure the existing and upcoming Agricultural Policy Framework addresses the needs of canola farmers including business risk management, marketing and research. Maintain support for federal and shared funded programs. Agricultural Trade - Support multi-lateral and bi-lateral trade negotiations and policies that provide more free and open access to existing and new markets through reduced tariffs and non-tariff trade barriers on canola and its products. Support the modernization of the World Trade Organization (WTO) as a mechanism to promote rules-based trade. Support additional government resources to help solve technical trade barriers.

Environment and international trade: to advance the good management practices that are implemented on canola farms that contribute to environmental stewardship and competitive markets for farmers and to advance the canola biodiesel market domestically and abroad. Canada's Clean Fuel Regulations incentivizes the use of canola-based biofuels. Ensure Government recognizes and works with the agriculture sector to ensure farmers have access to skilled, competitive on-farm labour. Discussions concerning railway and port strikes as it relates to economic development and trade labour disruptions. Support right to repair and interoperability programs, policies, laws, and regulations that support farmer's choice and right to repair. Agricultural Trade - Support multi-lateral and bi-lateral trade negotiations and policies that provide more free and open access to existing and new markets through reduced tariffs and non-tariff trade barriers on canola and its products. Provide farmers necessary support through trade disruptions. Support the modernization of the World Trade Organization (WTO) as a mechanism to promote rules-based trade. Support additional government resources to help solve technical trade barriers. The creation and implementation of the Canada Water Agency and adoption of a pan-Canadian water monitoring framework have positive impacts for canola farmers. Support a review of the Canada Grains Act to modernize role of Canadian Grain Commission to align with needs of the grain sector. Income Tax Act and other financial regulations, policies or programs: to promote the fair treatment of farmers in any proposed changes to the Income Tax Act or other financial mechanism that may impact farmers financially. Ensure governments recognize the benefits that farmers provide to the environment. Including in relation to polices and regulations concerning carbon pricing, as it pertains to on-farm exemptions, offset protocols, rebates, and research. Climate change laws, policies, programs and regulations related to agriculture promote competitiveness and production on farms. Climate/Environment- Advance canola- based biofuel as part of the solution for climate change. Canada's Clean Fuel Standard (CFS) incentivizes the use of canola-based biofuels. Canadian Environmental Protection Act and Pest Control Products Act and regulations as it relates to agricultural pest control products. Support enhanced resources for federal regulatory bodies to make science-based decisions on crop protection products and seed varieties. Advocate for clear, science and risk-based approach to regulation of pesticides and new plant breeding innovation and that it is facilitative for trade. Canada Transportation Act and regulations as it relates to the transportation of grain. Advocate for a fair and efficient railway transportation system that serves the needs of grain producers. Agriculture - Work to ensure the existing and upcoming Agricultural Policy Framework addresses the needs of canola farmers including business risk management, marketing and research. Maintain support for federal and shared funded programs.

Advocate for place-based solutions to Canada’s biggest challenges, which support the region-specific mandates of public colleges and ensure local training needs are considered in policy development. Increase support to developing countries and other partner countries to build technical and vocational training capacity, strengthen skills development and education systems, and enhance Canada’s global education brand. Advocate for support for college-led research as a core component of federal research and innovation funding and policy. Discuss how colleges can support immigration programs, such as foreign credential recognition or international students, to meet Canada’s labour market needs, and share with officials impacts of policy changes on the college sector. Share with officials how colleges can support Canada’s training and workforce development needs to meet Canada’s biggest challenges. Share with officials the role of colleges and institutes in delivering high quality education for Canadians, and ensuring access to education for Canadians. Advance reconciliation through partnerships with Canada’s public colleges, institutes, CEGEPs, polytechnics, and Indigenous Institutes of Education. Promote the role and expertise of colleges in deepening Canada’s relationships with other countries. Promote the value of educational fair dealing in supporting colleges and institutes in their mandate to provide advanced skills and to enable them to better respond to the skills shortage. Increase investments and support to address colleges’ infrastructure needs to increase Canada’s training space and access in key high-demand fields that align with federal priority areas. Enable post-secondary institutions to obtain grants and loans to develop student housing projects, with additional supports for housing that supports students from vulnerable populations. Ensure Canada’s colleges and institutes have the necessary federal support to provide high-quality training for future healthcare professionals. Ensure the specific needs of institutions, including French institutions and those in minority linguistic communities, are taken into account when federal policies and programs are designed and delivered.

Targeted federal transfer payments for postsecondary education. Review of the SR&ED Tax Credit Program to encourage greater participation of small and medium-sized businesses and providing mechanisms for colleges and institutes to assist them in the process. Review of the Canada Student Loan Program with respect to increased grants, modernization and simplification measures and increased flexibility for students in debt repayment. Research integrity related issues with respect to the review of the federal granting agencies' policiy framework for research integrity and the Tri-Council Memorandum of Understanding on roles and Responsibilities in the Management of Federal Grants and Awards. Modification of the Employment Insurance Program to enable workers currently in the workforce to access funding for skills upgrading. Introduction of new tax measures to encourage employer/employee based training, address literacy training and essential skills as well as an increase in internships and apprenticeship opportunities. Increase domesting and international student mobility to the mid-point of other OECD countries. Increased federal investments with regard to college and institute costs of supporting applied research through the Indicrect Costs Program. Harmonization and simplification of immigration policies with respect to facilitating study and work permit processes. Federal Investment for a national college and institute mobility program for faculty and student exchanges between Francophone Institutions and Anglophone Institutions. Extension of the 100% GST exemption that has been afforded to municipalities to postsecondary institutions as recommended by the Standing Committee on Finance Expansion of the Natural Sciences and Engineering Research Council College and Community Innovation Program Examination of all federal training programs with the goal of eliminating fragmentation, short term funding and inequities for learners. Enhancement of the federal infrastructure policy with respect to college and institute infrastructure and acquisition of leading edge technology. Enhanced opportunities for Aboriginal learners, immigrants and disadvantaged groups to access postsecondary education and training and labour market. Discussions underway with the Global Affairs Canada regarding a proposal for a new partnership between colleges and institutes and the Pacific Alliance with respect to education and training. Discussions underway with the federal government for recognition of college and institute applied degrees as equal to university degrees as stipulated in a statement by the Council of Ministers. Discussions underway with Statistics Canada for current college and institute data. Discussions underway for a new international partnership program - Education for Employment which will support educational reform of technical education in Mozambique, Senegal and Tanzania. Direct 5% of federal investment in research to applied research, product development and commercialization carried out by colleges and institutes and their private sector partners Dedicated funding of college and institute facilities, technology and equipment Creation of a college and Institute Internship Program to expose more students to private sector research challenges. Changes to amend the Copyright Act with respect to support colleges and institutes in their mandate to provide advanced skills and to enable them to better respond to the skills shortage.

Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as well as the review times and processes conducted by Health Canada for the purpose of obtaining a notice of compliance. National Strategy for Drugs for Rare Disease as it relates to separate regulatory pathways for drugs for rare diseases and the government strategy. Monitoring and engaging the Government and Parliamentarians on policies and programs that would provide greater clarity and predictability in the tax outcomes and improvements to tax measures such as the Manufacturing & Processing (M&P) credit and the Scientific Research & Developmental (SR&ED). Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework. Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries Policies related to the National Strategy for Drugs for Rare Disease as it relates to separate regulatory pathway for drugs for rare diseases and the government strategy. Policies related to Subsequent Entry Biologics (SEBs) pertaining to Draft Guidance for Sponsors; Information and Submission requirements for SEBs, regulations and intellectual property policies, naming conventions Monitoring and engaging on the Government’s commitment (Budget, SFT, Fall Economic Update) to create a national strategy for drugs for rare diseases; create a new Canadian Drug Agency; and the implementation of national, universal pharmacare. Pharmaceutical policy and any negotiations of a Health Accord or agreement with the Provinces/Territories, as it relates to National Pharmacare/universal or catastrophic drug coverage, Drug policies & Pricing. The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability, and as it relates to Canada’s Biomanufacturing and Life Sciences Strategy. Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's biomanufacturing and life sciences sector strategy National Pharmacare (Bill C-64, An Act respecting pharmacare) Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies. Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products. Income Tax Act as it relates to biopharmaceutical industry. Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry, and related updates and to Federal budgetary policy. Discussions around the World Trade Organization consideration of a TRIPS Patent Waiver - Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility". The Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of importation legislation in the United States. Standing Committee on Finance (FINA) as it relates to pre-budget consultations. Pharmaceutical intellectual property protection as it relates to international trade agreements Patent Act and Patented Medicines (Notice of Compliance) Regulations, as it relates to the regulation of intellectual property, approval for therapeutic products, changes to modernize the Right of Appeal House of Commons Standing Committee of Science and Research (SRSR) as it relates to Science in Canada and/or any other pertinent legislative proposal before the committee House of Commons Standing Committee of Industry and Technology (INDU) as it

Postal service disruption and the significant hardships these disruptions cause for Canadians and on health charities We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Safe Long-Term Care Act with respect to persons affected by MS National Housing Strategy with respect for persons with MS and other chronic conditions and disabilities Measures and funding for the charitable sector generally Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Establishment of national strategy for neurological conditions, with respect to persons with MS and other neurological conditions. Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities CIHR as it relates to federal funding & long term investment in health research Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including MS care Canada Health Act and regulations, as it relates to long-term and home care Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

Private Career Colleges are not eligible to have students apply for Post Graduate Worker Permits. The NACC would like to see this changed as it believes their students are being disadvantaged and discriminated against. To do this there must be a directive from the ministerial level that will allow for post graduate students to make application for the worker permits.

Advocacy around Budget 2025 regarding the recent revisions to the Canada Student Loans and Grants Program. Support for a pilot program enabling international students at Regulated Career Colleges (RCCs) to qualify for Post-Graduate Work Permits (PGWP), linking study permits to in-demand jobs, enhanced quality assurance for international students, and anti-fraud measures in the regulated career college sector. Requesting equal access to input tax credits (GST/HST rebates) and inclusion in federal student aid, loan forgiveness, and repayment assistance programs, similar to public institutions. Promotion of employer-driven training, support for standardized national credential recognition (e.g., “Blue/Red Seal” programs), and advocacy for increased labour mobility and rapid response to workforce needs Matching funding to support training for military personnel, their spouses, and dependents to secure in-demand jobs. Advocacy for federal support of digital/remote program delivery, increased youth employment pathways, and partnership on public awareness campaigns about the role of regulated career colleges. Advocacy for expanding the Veterans Affairs Education & Training Benefit (ETB), developing scholarship programs for military spouses, and supporting veteran employment and transition strategies. Private Career Colleges are not eligible to have students apply for Post Graduate Worker Permits. The NACC would like to see this changed as it believes their students are being disadvantaged and discriminated against. To do this there must be a directive from the ministerial level that will allow for post graduate students to make application for the worker permits.